Key facts
- Elevate Movement’s last known valuation is $20.0M (Jan 2024).
- It has raised $13.9M; the latest was Later Stage VC ($500K) in Jan 2026.
- Notable investors include Beyond Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Elevate Movement
- ·The full record, as it builds
Funding rounds
No funding rounds for Elevate Movement are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elevate Movement
Developer of orthopaedic devices designed to improve mobility for individuals with neurological conditions. The company offers custom and ready-to-use ankle foot orthoses with dynamic support, rapid fabrication, and multi-planar adjustment, enabling patients and clinicians in clinical and rehabilitation settings to improve walking stability and reduce fall risk.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2019
- Employees
- 7
- Website
- elevatemovement.com/
- Ownership
- Privately Held (backing)
Elevate Movement doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elevate Movement shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elevate Movement in its N-PORT filings yet. We sweep new filings monthly.